Electrochemical probing of HIV enzymes using ferrocene-conjugated peptides on surfaces
- 6 October 2009
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 134 (12) , 2400-2404
Abstract
One of the current pathways to develop inhibitors that target different steps in the life cycle of the human immunodeficiency virus (HIV) is blocking the function of the HIV-related proteins such as HIV-1 integrase (HIV-1 IN), HIV-1 reverse transcriptase (HIV-1 RT) and HIV-1 protease (HIV-1 PR), which are essential proteins that control the ability of HIV to infect cells, produce new copies of the virus, or cause disease. We have demonstrated for the first time the detection of these enzymes at nanomolar levels using ferrocene (Fc)-conjugated peptides on gold microelectrodes. The interaction between the Fc-conjugated peptides and the enzymes was studied by cyclic voltammetry. As the protein concentration increased, the electrochemical behaviour of the surface-bound Fc- bioconjugate changed, indicating that HIV protein was binding to the peptide film and encapsulating the Fc redox center on the surface. The electrochemical responses shifted to higher potentials and decreased in the current intensity, as the concentrations of the HIV-1 enzymes increased. The optimization studies were performed by changing the pH and NaCl concentration. Control experiments involved the exposure of the Fc-conjugated peptides with all the enzymes. This general procedure can be readily applied in the future to the multiplexed detection of several HIV-related proteins, as well as the high-throughput screening of candidate inhibitors for AIDS therapy.Keywords
This publication has 22 references indexed in Scilit:
- The Management of Treatment‐Experienced HIV‐Infected Patients: New Drugs and Drug CombinationsClinical Infectious Diseases, 2009
- Viral Protease Inhibitors2009
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and InhibitionJournal of Molecular Biology, 2009
- Emergence of Drug Resistance in HIV Type 1–Infected Patients after Receipt of First‐Line Highly Active Antiretroviral Therapy: A Systematic Review of Clinical TrialsClinical Infectious Diseases, 2008
- HIV entry inhibitors and their potential in HIV therapyMedicinal Research Reviews, 2008
- Structural basis for drug resistance mechanisms for non-nucleoside inhibitors of HIV reverse transcriptaseVirus Research, 2008
- Integrase Inhibitors: A New Treatment Option for Patients with Human Immunodeficiency Virus InfectionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008
- AZT: An Old Drug with New PerspectivesCurrent Clinical Pharmacology, 2008
- HIV entry inhibitorsThe Lancet, 2007
- Locations of Anti-AIDS Drug Binding Sites and Resistance Mutations in the Three-dimensional Structure of HIV-1 Reverse TranscriptaseJournal of Molecular Biology, 1994